Effects of isoliquiritigenin on ovarian cancer cells

BACKGROUND: Ovarian cancer is one of the most fatal gynecologic malignancies, with most patients diagnosed at the late stage due to insidious onset and lack of early onset specific symptoms. Previous studies have implied that isoliquiritigenin (ILQ) is a promising chemopreventive agent against oral...

Descripción completa

Detalles Bibliográficos
Autores principales: Li, Nan, Yang, Liang, Deng, Xinna, Sun, Yanan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2018
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868625/
https://www.ncbi.nlm.nih.gov/pubmed/29606882
http://dx.doi.org/10.2147/OTT.S149295

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5868625/
https://www.ncbi.nlm.nih.gov/pubmed/29606882
http://dx.doi.org/10.2147/OTT.S149295

Ejemplares similares